Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (141-150 of 396) with videos related to

Pageof 40
Sort By:
The Annals of Thoracic Surgery|September 26, 2018
Cytoreductive Pleurectomy and Intrathoracic Chemohyperthermia for Pleural Relapse of ThymomasJean-Michel Maury, Gabrielle Drevet, Stéphane Collaud, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2025
Double-Click Strategy Combining CuAAC and (Thia-) Diels-Alder Reactions; Application Toward Peptide LabelingTimothé Maujean, Camille Van Wesemael, Laurine Tual, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case reportOlfa Trabelsi Grati, Leila Zemoura, Caroline Nhy, et al.
Bioconjugate Chemistry|December 19, 2022
Rapid and Highly Selective Fluorescent Labeling of Peptides via a Thia-Diels-Alder Cycloaddition: Application to ApelinTimothé Maujean, Patrick Wagner, Christel Valencia, et al.
Journal of Bone Oncology|January 19, 2026
Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS studyCyrille B Confavreux, Béatrice Bouvard, Nicolas Girard, et al.
Cancers|August 10, 2024
Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000-2020 French CohortClemence Basse, Matthieu Carton, Maud Milder, et al.
Oncology and Therapy|May 3, 2026
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST StudyBenoît Godbert, Elisa Gobbini, Yaacoub Khalife, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Insulin-like growth factor-1 receptor expression in thymic malignanciesNicolas Girard, Julie Teruya-Feldstein, Eden C Payabyab, et al.
Future Oncology (London, England)|May 1, 2020
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in <i>EGFR</i>-mutated non-small-cell lung cancer: a real life studyNicolas Girard, Denis Moro-Sibilot, Stéphane Bouée, et al.
Journal of Thoracic Disease|July 10, 2020
Frequency of <i>MET</i> exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patientsAnne Champagnac, Pierre-Paul Bringuier, Marc Barritault, et al.
Pageof 40

Showing results (141-150 of 396) with videos related to

Sort By:
Pageof 40
The Annals of Thoracic Surgery|September 26, 2018
Cytoreductive Pleurectomy and Intrathoracic Chemohyperthermia for Pleural Relapse of ThymomasJean-Michel Maury, Gabrielle Drevet, Stéphane Collaud, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2025
Double-Click Strategy Combining CuAAC and (Thia-) Diels-Alder Reactions; Application Toward Peptide LabelingTimothé Maujean, Camille Van Wesemael, Laurine Tual, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2022
Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case reportOlfa Trabelsi Grati, Leila Zemoura, Caroline Nhy, et al.
Bioconjugate Chemistry|December 19, 2022
Rapid and Highly Selective Fluorescent Labeling of Peptides via a Thia-Diels-Alder Cycloaddition: Application to ApelinTimothé Maujean, Patrick Wagner, Christel Valencia, et al.
Journal of Bone Oncology|January 19, 2026
Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS studyCyrille B Confavreux, Béatrice Bouvard, Nicolas Girard, et al.
Cancers|August 10, 2024
Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000-2020 French CohortClemence Basse, Matthieu Carton, Maud Milder, et al.
Oncology and Therapy|May 3, 2026
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST StudyBenoît Godbert, Elisa Gobbini, Yaacoub Khalife, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2010
Insulin-like growth factor-1 receptor expression in thymic malignanciesNicolas Girard, Julie Teruya-Feldstein, Eden C Payabyab, et al.
Future Oncology (London, England)|May 1, 2020
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in <i>EGFR</i>-mutated non-small-cell lung cancer: a real life studyNicolas Girard, Denis Moro-Sibilot, Stéphane Bouée, et al.
Journal of Thoracic Disease|July 10, 2020
Frequency of <i>MET</i> exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patientsAnne Champagnac, Pierre-Paul Bringuier, Marc Barritault, et al.
Pageof 40